Search

everythinglearnresearchcommunity

for

Search:↓

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

New techniques in scalp reconstruction have improved cosmetic results and reduced complications, especially for large defects.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Combination therapy works best for female hair loss, increasing density and thickness.

Iron deficiency might contribute to hair loss in women.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.

Microneedling with platelet-rich plasma helps dog hair regrow faster than microneedling alone.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.